Asia Pacific Advanced Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial), By Application (Chronic Wounds, Acute Wounds), By End-use, By Country, And Segment Forecasts, 2025 - 2030
Asia Pacific Advanced Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial), By Application (Chronic Wounds, Acute Wounds), By End-use, By Country, And Segment Forecasts, 2025 - 2030
initiative, ASEAN member states will continue to collaborate with the other partners to prevent human deaths caused by dog-mediated rabies. Several ASEAN member states are facing challenges in achieving the goal set by The ASEAN Rabies Elimination Strategy (ARES) to eradicate rabies. In most ASEAN countries, rabies is still widespread among dogs and rabid dog bites are responsible for almost all human instances of the disease in the region. Vaccination in dogs is considered to be the most affordable method of preventing human rabies.
In ASEAN countries, rabies is a serious public health concern. It has significant adverse effects on human health, the economy, and animal welfare. The primary reservoir and transmitter of rabies in the region are domestic dogs. Lack of funding, a lack of political commitment to rabies control initiatives, a lack of agreement on a strategy, weak intersectoral coordination, insensitive surveillance systems, an inadequate management structure, limited access to modern rabies vaccines, supply issues, a lack of public awareness and cooperation, myths, and religious concerns are all key challenges to rabies control programs. Most ASEAN nations have an endemic canine rabies issue. However, widespread immunization can reduce disease in dog population. The majority of policy and decision-making is done at the national level, therefore developing, and implementing rabies management policies can benefit from a thorough understanding of the costs associated with preventative and control measures with adequate vaccine supply.
Companion animals accounted for the largest revenue share of over 95.0% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period
The hospital/clinical pharmacy segment accounted for the largest revenue share of over 45.0% in 2024
The e-commerce segment is anticipated to grow at the fastest CAGR over the forecast period. This growth is attributed to the increasing trend of digital platforms and their adoption among people due to their convenience
The Thailand market is anticipated to grow at a significant CAGR over the forecast period
Please note The report will be delivered in 2-3 business days upon order notification.
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Asia Pacific Advanced Wound Care Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
3.2.1.2. Introduction of innovative and advanced wound products
3.2.1.3. Rising geriatric population
3.2.1.4. Increasing number of road accidents, trauma cases, and burns
3.2.2. Market Restraint Analysis
3.2.2.1. Delayed diagnosis and lower treatment rates in an emerging nation
3.2.2.2. High cost of advanced wound care products and chronic wound treatments
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Asia Pacific Advanced Wound Care Market Analysis Tools
3.3.1. INDUSTRY ANALYSIS - PORTER’S
3.3.2. Swot Analysis, by PEST
Chapter 4. Asia Pacific Advanced Wound Care Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Asia Pacific Advanced Wound Care Market, by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Moist
4.5.1. Moist Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5.2. Foam Dressings
4.5.2.1. Foam Dressings Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5.2.2. Adhesive
4.5.2.2.1. Adhesive Foam Dressings Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5.2.3. Non-adhesive
4.5.2.3.1. Non-adhesive Foam Dressings Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5.3. Superabsorbent Dressings
4.5.3.1. Superabsorbent Dressings Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5.4. Film Dressings
4.5.4.1. Film Dressings Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5.5. Hydrocolloid Dressings
4.5.5.1. Hydrocolloid Dressings Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5.6. Alginate Dressings
4.5.6.1. Alginate Dressings Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5.7. Hydrogel Dressings
4.5.7.1. Hydrogel Dressings Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5.8. Collagen Dressings
4.5.8.1. Collagen Dressings Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5.9. Charcoal Dressings
4.5.9.1. Charcoal Dressings Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5.10. Wound Contact Layers
4.5.10.1. Wound Contact Layers Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5.11. Greasy Gauzes
4.5.11.1. Greasy Gauzes Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5.12. Other Advanced Dressings
4.5.12.1. Other Advanced Dressings Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.6. Antimicrobial
4.6.1. Antimicrobial Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.6.2. Silver
4.6.2.1. Silver Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.6.3. Non-Silver
4.6.3.1. Non-silver Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.6.3.2. Honey
4.6.3.2.1. Honey Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.6.3.3. Iodine
4.6.3.3.1. Iodine Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.6.3.4. Chitosan
4.6.3.4.1. Chitosan Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.6.3.5. PHMB
4.6.3.5.1. PHMB Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.6.3.6. Others
4.6.3.6.1. Others Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.7. Active
4.7.1. Active Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.7.2. Biomaterials
4.7.2.1. Biomaterials Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.7.3. Skin-substitute
4.7.3.1. Skin-substitute Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.7.4. Growth factors
4.7.4.1. Growth Factors Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.8. Wound Cleanser Products
4.8.1. Wound Cleanser Products Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.8.2. Wetting Agents
4.8.2.1. Wetting Agents Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.8.3. Antiseptic
4.8.3.1. Antiseptic Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.8.4. Moisturizers
4.8.4.1. Moisturizers Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.8.5. Pulsed Lavage Systems
4.8.5.1. Pulsed Lavage Systems Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.8.5.2. Disposable
4.8.5.2.1. Disposable Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.8.5.3. Reusable
4.8.5.3.1. Reusable Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.8.5.4. Semi Disposable
4.8.5.4.1. Semi Disposable Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.8.6. Others
4.8.6.1. Others Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.9. Compression Bandages
4.9.1. Compression Bandages Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.9.2. Long-Stretch Elastic Bandages
4.9.2.1. Long-Stretch Elastic Bandages Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.9.3. Short Stretch Bandages
4.9.3.1. Short Stretch Bandages Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.9.4. Multi-layer Bandages
4.9.4.1. Multi-layer Bandages Market Estimates and Forecasts, 2018 to 2030 (USD Million)
Chapter 5. Asia Pacific Advanced Wound Care Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Asia Pacific Advanced Wound Care Market Movement Analysis
5.3. Asia Pacific Advanced Wound Care Market Size & Trend Analyses, by Application, 2018 to 2030 (USD Million)
5.4. Chronic wounds
5.4.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.4.2. Diabetic Foot Ulcers
5.4.2.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.4.2.2. Pressure Ulcers
5.4.2.2.1. Pressure Ulcers Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.4.2.2.2. Stage 1
5.4.2.2.2.1. Stage 1 Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.4.2.2.3. Stage 2
5.4.2.2.3.1. Stage 2 Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.4.2.2.4. Stage 3
5.4.2.2.4.1. Stage 3 Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.4.2.2.5. Stage 4
5.4.2.2.5.1. Stage 4 Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.4.2.2.6. Deep Tissue Injury
5.4.2.2.6.1. Deep Tissue Injury Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.4.2.3. Venous Leg Ulcers
5.4.2.3.1. Venous Leg Ulcers Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.4.2.4. Other Chronic Wounds
5.4.2.4.1. Other Chronic Wounds Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.5. Acute wounds
5.5.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.5.1.1. Surgical & Traumatic Wounds
5.5.1.1.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.5.1.2. Burns
5.5.1.2.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.5.1.2.2. 1st Degree Burns
5.5.1.2.2.1. 1st Degree Burns Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.5.1.2.3. 2nd Degree Burns
5.5.1.2.3.1. 2nd Degree Burns Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.5.1.2.4. 3rd Degree Burns
5.5.1.2.4.1. 3rd Degree Burns Market Estimates and Forecasts, 2018 to 2030 (USD Million)
Chapter 6. Asia Pacific Advanced Wound Care Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Asia Pacific Advanced Wound Care Market Movement Analysis
6.3. Asia Pacific Advanced Wound Care Market Size & Trend Analyses, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.5. Outpatient Facilities
6.5.1. Outpatient Facilities Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.6. Home Care
6.6.1. Home Care Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others Market Estimates and Forecasts, 2018 to 2030 (USD Million)
Chapter 7. Asia Pacific Advanced Wound Care Market: Country Estimates & Trend Analysis By Product, Application and End Use
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. Asia Pacific
7.4.1. China
7.4.1.1. Key Country Dynamics
7.4.1.2. Competitive Scenario
7.4.1.3. Regulatory Scenario
7.4.1.4. Reimbursement Scenario
7.4.1.5. China Advanced Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. India
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Scenario
7.4.2.4. Reimbursement Scenario
7.4.2.5. India Advanced Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Australia
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Scenario
7.4.3.4. Reimbursement Scenario
7.4.3.5. Australia Advanced Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. Singapore
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Scenario
7.4.4.4. Reimbursement Scenario
7.4.4.5. Singapore Advanced Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. Vietnam
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Scenario
7.4.5.4. Reimbursement Scenario
7.4.5.5. Vietnam Advanced Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Scenario
7.4.6.4. Reimbursement Scenario
7.4.6.5. Thailand Advanced Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Indonesia
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Scenario
7.4.7.4. Reimbursement Scenario
7.4.7.5. Indonesia Advanced Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Scenario
7.4.8.4. Reimbursement Scenario
7.4.8.5. South Korea Advanced Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.9. South Korea
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Scenario
7.4.9.4. Reimbursement Scenario
7.4.9.5. South Korea Advanced Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.10. Hong Kong
7.4.10.1. Key Country Dynamics
7.4.10.2. Competitive Scenario
7.4.10.3. Regulatory Scenario
7.4.10.4. Reimbursement Scenario
7.4.10.5. Hong Kong Advanced Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.11. Malaysia
7.4.11.1. Key Country Dynamics
7.4.11.2. Competitive Scenario
7.4.11.3. Regulatory Scenario
7.4.11.4. Reimbursement Scenario
7.4.11.5. Malaysia Advanced Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Mölnlycke Health Care AB
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. 3M
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Smith & Nephew
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Baxter International
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Cardinal Health
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Medline Industries, Inc.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. ConvaTec Inc.
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Johnson & Johnson Services, Inc.
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Integra LifeSciences Corporation
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. B. Braun SE
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. Coloplast Corp.
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. Urgo Medical
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives
8.3. Heat Map Analysis/ Company Market Position Analysis
8.4. Estimated Company Market Share Analysis, 2024